Cooley LLP advised Exscientia on the deal while Goodwin Procter represented Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, BofA Securities and Barclays Capital...
Exscientia’s $510.4 Million IPO
Exscientia’s $225 Million Series D Funding Round
Cooley LLP advised Exscientia on the deal. Exscientia, a clinical-stage pharmatech company, announced its $225 million Series D funding round led by SoftBank Vision Fund 2, which...